Skip to main content
. 2020 Jan 20;14(6):204–213. doi: 10.5489/cuaj.6101

Fig. 1.

Fig. 1

Overview of standard of care for bladder cancer. *All evaluations should comprise of cystoscopy, urine cytology, and random bladder biopsies for CIS. Papillary disease at 3 months requires resection. Any recurrence while on BCG with muscle-invasive disease is managed according to the MIBC pathway. BCG: bacillus Calmette-Guérin; CIS: carcinoma in situ; MIBC: muscle-invasive bladder cancer; NMIBC: non-muscle-invasive bladder cancer.